Department of Health Home A to Z Topics About the Department of Health Site Map Contact Us - Opens in a new window

Epidemiology Home

Health Topics (A-Z)

Related Links

Contact Us

   

EPI UPDATE

A weekly publication by the Bureau of Epidemiology

For February 23, 2000

"The reason for collecting, analyzing and disseminating information on a disease is to control that disease. Collection and analysis should not be allowed to consume resources if action does not follow."

--Foege WH et al. Int. J of Epidemiology 1976; 5:29-37.

Richard S. Hopkins, MD, MSPH, Bureau Chief, State Epidemiologist

Don Ward, Surveillance Section Administrator, Epi Update Managing Editor

Jill H. Parker, MSP, Epi Update Editor

Bureau of Epidemiology Frequent Contributors:

Steven Wiersma, MD, MPH,

Deputy State Epidemiologist

William J. Bigler, PhD, MS,

Senior Epidemiologist

Jodi Baldy, MPH,

Biological Scientist IV

Ursula E. Bauer, PhD,

Chronic Disease Epidemiologist

John Werth, MA,

Bureau Education Coordinator

Lisa Conti, DVM, MPH,

State Public Health Veterinarian

Regional Epidemiologists:

Dolly Katz, PhD, MPH,

SE Florida

Roger Sanderson, RN, MA,

SW Florida

Carina Blackmore, MS Vet. Med., PhD,

NE Florida Carina Blackmore, MS Vet. Med., PhD,

Zuber Mulla, MSPH,

Central Florida Carina Blackmore, MS Vet. Med., PhD,

Gérard Krause, MD, DTMH,

NW Florida

Please print out this material and share with epidemiology staff, county health department directors, administrators, medical directors, nursing directors, environmental health directors and others with an interest in information of this type. Thank you.

The Bureau of Epidemiology is available 24 hours a day, 7 days a week for consultation at our main number (850/245-4401) PLEASE NOTE: Consultation after 5 p.m. & on weekends is intended for emergencies.

In this issue:

1. Important: Proposed Revisions to Chapter 64D-3, F.A.C.

2. Malaria Prophylaxis: CDC Notice - Dominican Republic

3. Lead Poisoning Cases from a Folk Remedy in Hillsborough County

4. Florida Influenza Program Summary Update: Week 6 (week ending February 12, 2000)

5. Influenza Sentinel Surveillance Network: Map of Influenza Activity in Florida, January 16 through February 15, 2000

6. Florida Past – Punch Cards and Electronic Tabulation

7. Weekly Disease Table: Week 7

1. Important: Proposed Revisions to Chapter 64D-3, F.A.C.

Jodi Baldy, MPH, Bureau of Epidemiology

Proposed revisions to Rule 64D-3 are in the "Notice of Rule Making" phase. The proposed rule and supporting documents have been sent to Department of Health (DOH) county health department directors and nursing staff directors, the DOH laboratories, the large private laboratories, the DOH bureau chiefs, the Florida Children’s Forum, and the childcare licensing program of the Department of Children and Families. The proposed revisions were published in the February 11th issue of the Florida Administrative Weekly.

The proposed amendments update the list of notifiable diseases and conditions and procedural rules for reporting of communicable diseases and conditions. In summary, Rule 64D-3 is being amended to:

1) clarify certain definitions;

2) add Q Fever to, and delete Amebiasis and Toxic Shock Syndrome from, the list of notifiables;

3) clarify language related to confidentiality of reports and reports to medical facilities;

4) add language to further define quarantine and control procedures for specific communicable diseases;

5) clarify the definition of a sensitive situation;

6) add hepatitis A to the list of sexually transmissible diseases;

7) amend specific reporting procedures for sexually transmissible diseases; and

8) incorporate by reference forms for reporting of congenital anomalies and guidelines for outbreaks of enteric disease in child care settings.

Technical changes include corrections and additions to rule references and statute citations.

If requested within 21 days of the February 11, 2000 notice published in the Florida Administrative Weekly, a hearing will be held at the date, time and place below:

TIME AND DATE: 9:00 a.m. on March 6, 2000.

PLACE: Department of Health, E. Carlton Prather Building, Capital Circle Office Center, 2585 Merchant’s Row Blvd, Room 310-A.

Comments and responses may be made in writing via email, fax, or regular mail to be received on or before the scheduled hearing date. Please use this opportunity for input –this is an important revision covering a number of communicable disease issues.

The full text of the proposed rule and a copy of the enteric disease guidelines can be found on the Bureau of Epidemiology web page at www.doh.state.fl.us (choose epidemiology as subject). Click on the red text "Proposed Revisions to Chapter 64D-3, F.A.C.

2. Malaria Prophylaxis: CDC Notice - Dominican Republic

Notice

In December 1999, CDC revised its recommendations for travelers to the Altagracia Province of the Dominican Republic. This revision was based on reports of a localized outbreak of malaria in this province, which included cases in tourists who stayed only in resort areas. Tourists traveling to resorts in the Altagracia Province were advised to take chloroquine prophylaxis. Control measures undertaken by the Ministry of Health in the Dominican Republic have eliminated local transmission in and around these resort areas. Intensified surveillance indicates that the outbreak is over. Therefore, as of February 17, 2000, CDC is no longer recommending chloroquine prophylaxis for travelers to resort areas in the Dominican Republic, but continues to recommend it for travelers to rural areas of the Dominican Republic, excluding resort areas. CDC together with the Ministry of Health in the Dominican Republic will be monitoring the situation closely.

For further information, please see CDC's Internet travel information.

Or call the CDC voice information system.

To receive fax information.

3. Lead Poisoning Cases from a Folk Remedy in Hillsborough County

Gregg Rottler, MPH, Hillsborough County Health Department

A 6-month-old boy and his 3-year-old brother recently underwent chelation therapy at Tampa General Hospital after blood lead levels of 83 ug/dl and 68 ug/dl, respectively, were detected. Neither child appeared to exhibit acute symptoms of lead poisoning.

The older child was initially diagnosed with the condition after visiting the Hillsborough County Health Department’s Ruskin Clinic for a nail fungus infection. A physical was performed on the child, which included a lead test. The younger child was diagnosed with lead poisoning after the health department’s lead investigator, Cynthia Keeton, wasn’t able to identify any environmental sources of contamination and suggested that the entire family be tested for lead.

When questioned by the investigator about the use of home remedies, the mother stated that she had given her children an orange-colored powder called Azarcon that she imported from Mexico. She said she used it to treat for "empacho", a folk term for gastrointestinal illness. An analysis from the state’s Jacksonville lab indicated that the substance contained 82% lead.

The use of lead-containing folk remedies can lead to permanent neurological impairment and death. Azarcon is known by other names including Ruedo, Alarcon, Maria Luisa, Ligo, and Corol. It is used as an ingredient by Mexican druggists in topical treatments for skin disorders. Another lead-containing folk remedy imported from Mexico for empacho is Greta, which is a yellow-colored powder. Greta is sold in hardware stores for use as a pottery glaze. The medicinal use of lead has been documented in other ethnic communities as well.

Health care providers should routinely inquire about the use of home remedies while performing health screenings in demographic regions with immigrant populations. Culturally competent educational efforts stressing the health hazards associated with these home remedies may help to reduce exposures.

Editorial Comment: Azarcon is particularly dangerous because it may be given to children who are suffering from gastrointestinal distress that is itself a product of lead poisoning. - RSH

4. Florida Influenza Program Summary Update: Week 6 (week ending February 12, 2000)

Roger Sanderson, RN, MA, Bureau of Epidemiology

National:

Since October 3, 1999, the World Health Organization (WHO) and the National Respiratory and Enteric Virus Surveillance System (NREVSS) laboratories have tested 66,810 respiratory specimens for influenza, from which 11,957 (18%) influenza isolates have been recovered. Influenza A accounted for 11,935 of the 11,957 (99.8%) isolates with 22 isolates being influenza B (0.2%). Of the 3,003 influenza A viruses sub-typed 2,980 (99.2%) were A (H3N2) and 23 (0.8%) were A (H1N1). Both influenza A and B were isolated in Florida during this time period.

During week 6, influenza activity was reported as widespread in 4 states (Arizona, New York, Pennsylvania, and Tennessee). Regional influenza activity was reported in 17 states (Alabama, Colorado, Georgia, Indiana, Kentucky, Louisiana, Maryland, Massachusetts, Michigan, Missouri, North Carolina, Ohio, South Carolina, Utah, Vermont, Virginia, and Wisconsin). Sporadic influenza activity was reported in 26 states, no influenza activity was reported in 1 state, and 2 states did not report. This continues the decrease in overall influenza activity seen in previous weeks. During Week 5 widespread influenza activity was reported in 8 states, regional activity in 17 states and sporadic in 21 states and 4 states did not report.

During Week 6, the proportion of deaths due to pneumonia and influenza (P&I) was 9.9% as reported by the vital statistics offices of 122 U.S. cities. This percentage is above the epidemic threshold of 7.6% for Week 6 and is unusually high. The percentage of pneumonia and influenza deaths has exceeded threshold values for this time of year for 20 of the past 21 weeks. The current season’s P&I figures must be interpreted with caution because important changes have taken place in this year’s case definition that may be contributing to higher estimates of P&I mortality than in previous years. Tampa, St. Petersburg, Jacksonville and Miami are the Florida cities that contributed to this report.

Florida:

Since the beginning of Week 6 (February 6, 2000) laboratory confirmed isolates of influenza A H3N2/Sydney-like were reported from Broward, Palm Beach and Hillsborough counties. Influnza A H3N2 has also been isolated from Alachua, Baker, Brevard, Clay, Collier, Duval, Escambia, Gadsden, Indian River, Lake, Leon, Martin, Miami-Dade, Orange, Pasco, Pinellas, Sarasota, and Volusia counties since October 1, 1999. The state's second Influenza B/Yamanashi-like isolate was from a specimen collected on February 2, 2000 from Broward County. Previously, an influenza B/Yamanashi-like isolate was collected from Indian River County. Untyped isolates of influenza A have been reported from Brevard, DeSoto, and Manatee counties. Antigens from both influenza A/Sydney and influenza B/Yamanashi are included in the 1999-2000 influenza vaccine.

Of the total patient visits to sentinel physicians for Week 6, 2% were due to ILI. This is the same as week 5 and is within the expected range of 0-3%. This week influenza-like illness was reported from providers in 14 (Broward, Collier, Duval, Escambia, Hillsborough, Indian River, Leon, Marion, Palm Beach, Pasco, Pinellas, Polk, Sarasota, and St. Lucie counties) of the 29 Florida counties participating in the National Sentinel Physicians Surveillance Network.

Florida has experienced a decline in influenza activity since the first week in January when the ILI in peaked at 5%. This was one week later than the national peak at 6% during Week 52.

5. Influenza Sentinel Surveillance Network: Map of Influenza Activity in Florida, January 16 through February 15, 2000
Carina Blackmore, MS Vet Med, PhD

 

 

 

 

 

 

 

 

 

 

 

 

 

6. Florida Past – Punch Cards and Electronic Tabulation

William J. Bigler, PhD

When working computerized files it is hard to imagine just how difficult it might have been to sort records and compile information when it had to be done by hand. The following excerpt from the State Board of Health 1921-22 Annual Report announced a technological breakthrough that made data analysis considerably easier for the public health researchers of that time. New equipment was added and modifications were made over the years. Still, this basic system of record management and data tabulation for morbidity and mortality information remained essentially the same until computers entered the scene in the mid-1960’s.

A punch card is made for each birth and death record and for each case of notifiable disease. This punch card is a history record and provides the means by which all tabulations are compiled.

Fifty-one thousand five hundred and ninety-five (51,595) punch cards were made for records received during 1921, and sixty-three thousand one hundred and forty-one (63,141) for 1922, making a total of one hundred and fourteen thousand seven hundred and thirty-six (114,736) cards punched.

In order to tabulate the records by months, by cities, by counties, by diseases or any other way desired, the cards are sent through the sorting machine. This electrical machine sorts the cards at the rate of one hundred and sixty (160) per minute, and in addition to the speed accomplished, the advantage of mechanical accuracy must not be overlooked.

After the cards are sorted they are sent through the electrical tabulating machine and the totals taken off for the information as sorted. This system of tabulating is modern in every way, so that we feel proud of the department and equipment which makes it possible to keep the health index up-to-date and available for all departments and health workers within the state.

The punch cards are carefully filed and preserved so that if special studies in research work for diseases or other information is desired, there will be no trouble in tabulating the information for a period of years.

7. Weekly Disease Table: Week 7

County-Confirmed Cases, Sorted Alphabetically by Disease

(NR represents years that the disease lacked status as a reportable condition)

DISEASE

1997 TO DATE

1998 TO DATE

1999 TO DATE

3 YEAR AVERAGE

TO DATE

1999 TOTAL CASES

2000 TO DATE

Amebiasis

3

2

2

2.3

63

0

Anthrax

0

0

0

0

0

0

Botulism

0

0

0

0

4

0

Brucellosis

0

0

0

0

3

0

Campylobacteriosis

65

57

65

62.3

949

52

Ciguatera

0

0

0

0

2

0

Cryptosporidiosis

4

12

2

6

166

5

Cyclosporiasis

0

0

0

0

6

0

Dengue

0

0

1

0.3

5

1

Diphtheria

0

0

0

0

0

0

E. coli O157:H7

5

2

3

3.3

54

2

E. coli, other (known serotype)

1

0

1

0.7

14

1

Ehrlichiosis, Human

0

0

0

0

2

0

Encephalitis, Eastern Equine

0

0

0

0

2

0

Encephalitis, St. Louis

0

0

0

0

3

0

Encephalitis, other (known organism)

1

2

0

1

5

0

Encephalitis, post-infectious1

0

0

1

0.3

12

0

Giardiasis (acute)

98

96

80

91.3

1260

48

Haemophilus influenzae, invasive1

2

10

5

5.7

48

1

Hansen’s Disease (Leprosy)

0

0

0

0

3

0

Hantavirus Infection

0

0

0

0

0

0

Hemolytic Uremic Syndrome

0

0

0

0

7

0

Hemorrhagic Fever

0

0

0

0

0

0

Hepatitis A

46

52

42

46.7

776

39

Hepatitis B

15

19

19

17.7

546

23

Hepatitis C2

NR

NR

NR

NR

53

2

Hepatitis Non-A, Non-B

3

7

0

3.3

10

1

Hepatitis, perinatal B2

NR

NR

NR

NR

2

0

Hepatitis, unspecified

0

0

0

0

14

3

Hepatitis, +HBsAg, pregnant woman2

NR

NR

NR

NR

147

12

Lead Poisoning

85

188

24

99

856

53

Legionellosis

1

6

4

3.7

30

7

Leptospirosis

0

0

0

0

1

0

Listeriosis2

NR

NR

NR

NR

32

3

Lyme Disease

0

1

1

0.7

49

1

Malaria

7

2

8

5.7

86

1

Measles

0

1

0

0.3

2

0

Meningococcal Disease (N. meningitidis)

23

15

14

17.3

133

20

Meningitis, Group B Streptococci

2

1

2

1.7

16

0

Meningitis, Haemophilus influenzae1

2

3

2

2.3

13

0

Meningitis, Streptococcus pneumoniae

12

19

17

16

95

16

Meningitis, Listeria monocytogenes

0

1

0

0.3

11

1

Meningitis, other bacterial (including unspecified)

3

4

4

3.7

62

5

Mercury Poisoning

0

0

0

0

7

0

Mumps

3

2

0

1.7

6

0

Neurotoxic Shellfish Poisoning2

0

0

0

0

0

0

Pertussis

1

8

3

4

80

1

Pesticide Poisoning

0

1

0

0.3

32

1

Plague

0

0

0

0

0

0

Poliomyelitis

0

0

0

0

0

0

Psittacosis

0

0

0

0

0

0

Rabies, Animal

39

24

21

28

176

14

Rocky Mountain Spotted Fever

1

0

0

0.3

3

0

Rubella, including congenital

0

0

0

0

1

0

Salmonellosis

129

148

146

141

2968

105

Shigellosis

103

102

99

101.3

1454

84

Smallpox2

NR

NR

NR

NR

0

0

Staphylococcus aureus, (GISA/VISA)2

NR

NR

NR

NR

1

0

Staphylococcus aureus, (GRSA/VRSA)2

NR

NR

NR

NR

0

0

Streptococcal Disease, invasive Group A

1

3

8

4

99

9

Streptococcus pneumoniae, invasive disease

29

62

43

44.7

714

134

Tetanus

0

0

0

0

3

0

Toxic Shock Syndrome

0

2

0

0.7

8

0

Toxoplasmosis

1

3

0

1.3

15

0

Typhoid Fever

1

4

3

2.7

23

0

Vibrio cholerae (serogrp O1)

0

0

0

0

1

0

Vibrio cholerae (serogrp Non-O1)

1

0

2

1

9

0

Vibrio vulnificus

1

0

1

0.7

22

0

Vibrio other (including unspecified)

0

0

3

1

47

3

Yellow Fever

0

0

0

0

0

0

1 Haemophilus influenzae can be the agent responsible for disease under three of the reportable conditions listed-: "Haemophilus influenzae, invasive" and under "Encephalitis, post infectious." Cases of Haemophilus influenzae meningitis are reported under "Meningitis, H. influenzae."

2 Total cases for 1999 may only reflect a six month time period since the disease was not reportable until July 1999.

This page was last modified on: 10/29/2012 01:11:09